Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Cash flows from operating activities:
Net (loss)	$ (2,420,649)	$ (521,414)
Adjustments to reconcile net (loss) to net cash (used in) operating activities
Common stock issued for services rendered	232,516	234,036
Amortization of discount to note payable	221,370
Derivative expense	(1,607,506)
Changes in fair value of derivative liabilities	(963,167)
Accounts payable and accrued expenses	23,525	(34,578)
Due from related party	(122,341)	(12,054)
Net cash (used in) operating activities:	(665,239)	(334,010)
Patent		(7,000)
Net cash (used in) investing activities:		(7,000)
Proceeds from issuance of common stock	97,500	250,000
Proceeds from exercise of warrants	131,000
Proceeds from issuance of note payable	2,400,000
Net cash provided by financing activities	2,628,500	250,000
Net increase/(decrease) in cash and cash equivalents	1,963,261	(91,010)
Cash and cash equivalents, beginning of year	95,069	152,526
Cash and cash equivalents, end of year	2,058,331	61,516
Interest
Income taxes